Navigation Links
Cornerstone Pharmaceuticals' Cancer Metabolism Inhibitor, CPI-613, Showing Promise in Phase I Trial for Acute Myeloid Leukemia
Date:12/12/2011

SAN DIEGO, Dec. 12, 2011 /PRNewswire/ -- Cornerstone Pharmaceuticals today announced its first-in-class cancer metabolism inhibitor drug will be featured in a poster session at the 53rd Annual Meeting and Exposition of the American Society of Hematology (ASH).  Findings from the study (http://bit.ly/scSBqO) will be presented along with preclinical findings at ASH from a Phase I clinical trial of CPI-613 in refractory acute leukemias. In August 2011, CPI-613 received FDA orphan drug designation for the treatment of acute myeloid leukemia (AML).

CPI-613 is the subject of a Phase I clinical single agent trial to evaluate safety, tolerability, maximum tolerated dose, efficacy, and pharmacokinetics for patients with relapsed and refractory hematologic malignancies. To date, eleven patients have been treated with at least one cycle of CPI-613. Interim clinical data suggests that altered lipid and mitochondrial metabolism are viable targets in acute leukemias. CPI-613 is a novel agent that has activity against several acute leukemia cell lines in vitro and in vivo and demonstrates activity in patients with relapsed AML and Myelodysplastic Syndrome (MDS). Several patients experienced significant clinical benefit, including a sustained complete remission when treated with CPI-613 as a single agent.  Only minor toxicities were observed.

According to the National Cancer Institute, one in 77 men and women will be diagnosed with leukemia during their lifetime. In adults these diseases disproportionally affect the elderly with a median age of onset of 72 for acute myeloid leukemia. Patients over the age of 60 have less than 10 percent survival at five years. It is estimated that 12,950 Americans (6,830 men and 6,120 women) will
'/>"/>

SOURCE Cornerstone Pharmaceuticals
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Cornerstone Pharmaceuticals Adds Acclaimed Cancer Research Pioneer Robert A. Weinberg, Ph.D. to Its Scientific Advisory Board
2. Cornerstone Therapeutics to Host Conference Call to Discuss Financial Guidance for 2010
3. Cornerstone Therapeutics Provides a Response to FDA Warning Letter on Deconsal
4. Cornerstone Therapeutics to Present at the 30th Annual Cowen & Company Health Care Conference
5. Cornerstone Therapeutics to Host First Quarter 2010 Conference Call
6. Cornerstone Therapeutics To Present at Deutsche Banks 35th Annual Healthcare Conference
7. Cornerstone Therapeutics Announces Management Change
8. Cornerstone Therapeutics to Host Second Quarter 2010 Conference Call
9. Cornerstone Therapeutics Announces Collaboration with The Cough Company
10. Cornerstone Therapeutics Licenses Alpha-7 Technology to Targacept
11. Cornerstone Therapeutics Announces Development of Generic for Tussionex®
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... , Feb. 27, 2015 Pharmaceutical and ... managing multiple products for the same indication. This can ... that want to prevent one of their brands from ... According to recent research by benchmarking firm, Best ... as independent brands rather than together as part of ...
(Date:2/27/2015)... 2015  Acsis Inc., the market leader for supply ... that John DiPalo , Acsis, Chief Strategy Officer, ... Chain Executive 2015 Provider Pro to Know. The ... to help prepare their companies, and customers, supply chains ... year,s list of Provider Pros to Know is featured ...
(Date:2/27/2015)... VANCOUVER, Canada and HOUSTON, TX ... ("ESSA" or the "Company") (TSX-V: EPI) and Bloom Burton ... have released from voluntary contractual lock-up (the "Lock-Up") 2,353,130 ... of the Common Shares originally subject to the Lock-Up. ... shares will be free trading immediately upon release from ...
Breaking Medicine Technology:New Report Details How to Expand a Pharmaceutical Product Portfolio without Cannibalizing an Established Brand 2Acsis CSO John DiPalo Named Supply & Demand Chain Executive 2015 Pro to Know 2ESSA Pharma and Bloom Burton announce additional release of shares from voluntary lock-up agreement 2ESSA Pharma and Bloom Burton announce additional release of shares from voluntary lock-up agreement 3ESSA Pharma and Bloom Burton announce additional release of shares from voluntary lock-up agreement 4
... May 5, 2011 Cardiac Network, Inc. (Other OTC: CNWI.PK) ... 1-for-750 reverse stock split (the "Reverse Stock Split"). The Reverse ... and trading on May 6, 2011 (the "Effective Date"). On ... from "CNWI" to "CNWID" for approximately 20 business days, after ...
... ARAY ), a global leader in the field ... of fiscal year 2011, ended March 31, 2011. ... total revenue of $54.7 million, an increase of five percent ... of fiscal 2010. Total revenue during the third quarter of ...
Cached Medicine Technology:Cardiac Network Announces Reverse Stock Split 2Accuray Announces Results for Third Quarter of Fiscal 2011 2Accuray Announces Results for Third Quarter of Fiscal 2011 3Accuray Announces Results for Third Quarter of Fiscal 2011 4Accuray Announces Results for Third Quarter of Fiscal 2011 5Accuray Announces Results for Third Quarter of Fiscal 2011 6
(Date:2/28/2015)... The noted Friedman Dental Group of South ... relaunched their website. The new version of the site ... new section about their team members. Potential and current ... of each Friedman Dental Group team member including new ... to provide our patients with the opportunity to get ...
(Date:2/28/2015)... WI (PRWEB) February 28, 2015 ... designation recognizes Mercy Harvard Hospital as stroke capable by ... be brought via ambulance to Mercy Harvard Hospital. , ... state to indicate their ability to treat stroke according ... designation allows ambulances transporting stroke patients to bypass hospitals ...
(Date:2/28/2015)... February 28, 2015 Memphis, TN: MedixSafe ... 2015, for a new security reader named Guardian ... reader is a new biometric scanner that significantly ... new features, the new biometric scanner provides fast ... administrators. , MedixSafe narcotics lockers with ...
(Date:2/28/2015)... California (PRWEB) February 28, 2015 ... supported and showcased emerging brand at Houston Texas ... in Las Vegas sending its executive delegates headed ... of Business Development and Training Randolph Clarito. , ... (IFA), was held last February 4-7 and featured ...
(Date:2/27/2015)... Santa Clara, CA (PRWEB) February 27, 2015 ... Integrated Passive Devices (IPD), has introduced miniature, wire bondable, ... Brightness and Power LED markets. The ESD88NP ... high transient currents away from sensitive LED and IC ... compared to Multilayer Varistors (MLV). All devices meet ...
Breaking Medicine News(10 mins):Health News:Friedman Dental Group Announces Their Updated Website 2Health News:Mercy Harvard Hospital Recognized as Leader in Stroke Care - Javon Bea 2Health News:New Name Announced For Newest MedixSafe Readers – MedixSafe Vanguard 2Health News:1Heart Caregiver Services Showcases Emerging Brand at Franchise Expo South and IFA Annual Convention 2Health News:1Heart Caregiver Services Showcases Emerging Brand at Franchise Expo South and IFA Annual Convention 3Health News:OnChip Introduces New Series of Space Saving Bare-die Zener Diodes for Transient Voltage Suppression 2Health News:OnChip Introduces New Series of Space Saving Bare-die Zener Diodes for Transient Voltage Suppression 3
... and calcium have been the focus of much research since ... in 1997. Known as Dietary Reference Intakes, the values for ... nutrition and provide the scientific basis for the development of ... DRIs for these two nutrients are presented in a new ...
... found an effective two-part treatment for microtears in the hamstring: ... with "dry-needling," in which repeated needle punctures cause controlled internal ... presented today at the annual meeting of the Radiological Society ... blood where it is needed at the site of a ...
... "We blame kids for being fat, we blame kids for being ... not feeding their kids right," says Terrance Wade, the Canada Research ... of these things are not based on individual choices because your ... Wade is completing a five-year study funded by the Heart ...
... (November 29, 2010) Whitehead Institute researchers have shown ... (miR-125b) can independently cause leukemia and accelerate the disease,s ... edition of the Proceedings of the National Academy of ... but in humans and mice, can upregulation of a ...
... We Die: Reflections on Life,s Final Chapter, Sherwin B. Nuland, ... of end-of-life care today, progress in palliative care, and areas ... published in 1994 and won the National Book Award for ... by describing the physical deterioration that occurs with heart attack, ...
... an innovative use of cell phone records, researchers at UCLA, ... that women appear to avoid contact with their fathers during ... on these high-fertility days and they hang up with them ... a UCLA associate professor of communication in whose lab the ...
Cached Medicine News:Health News:Researchers use patient's own blood to treat hamstring injury 2Health News:Up to 8 percent of Canadian children suffer from elevated blood pressure 2Health News:Tiny RNA shown to cause multiple types of leukemia 2Health News:Tiny RNA shown to cause multiple types of leukemia 3Health News:Contact with dads drops when women ovulate 2Health News:Contact with dads drops when women ovulate 3Health News:Contact with dads drops when women ovulate 4
... 2000 Pipette is a synonym for pipetting ... robust design, and superior operating comfort. Its ... the measuring stroke and blow-out as well ... system ensures utmost accuracy and precision. Ejection ...
Inquire...
... The Eppendorf Reference Series 2000 Pipette is ... stroke, a compact and robust design, and ... is used to operate the measuring stroke ... tip. Product features:Eppendorf "pipette/tip" system ensures utmost ...
... Eppendorf Reference Series 2000 Pipette is a ... a compact and robust design, and superior ... used to operate the measuring stroke and ... Product features:Eppendorf "pipette/tip" system ensures utmost accuracy ...
Medicine Products: